Email this article 
Hypertension and sex hormone levels in young and middle-aged men
- Authors: Orlova I.A.1, Sorokin E.D.1, Pavlova Z.S.1, Plisyuk A.G.1, Raevskii K.P.1, Kamalov A.A.1
-
Affiliations:
- Lomonosov Moscow State University
- Issue: Vol 80, No 3 (2025)
- Pages: 190-197
- Section: CARDIOLOGY AND CARDIOVASCULAR SURGERY: CURRENT ISSUES
- Published: 10.10.2025
- URL: https://vestnikramn.spr-journal.ru/jour/article/view/18077
- DOI: https://doi.org/10.15690/vramn18077
- ID: 18077
Cite item
Open Access
Access granted
Abstract
Background. Hypertension is a major cardiovascular condition and exhibits significant sexual dimorphism. The prevalence of hypertension in the general population could be associated with the state of sex hormone system to a large degree. Currently the data obtained on the relationship between sex hormones and blood pressure levels are insufficient.
Aims — to study the relationship between hypertension and sex hormone levels in young and middle-aged men in a retrospective cohort study setting.
Methods. A retrospective observational clinical trial was conducted. 698 medical records of male patients aged 18 to 59 years were analyzed. 508 patients with an average age of 41.1 ± 9.4 years, obesity prevalence of 48.2%, and hypertension prevalence of 52% were selected. Blood pressure levels, anthropometric data, levels of sex hormones, lipid panel and insulin resistance indicators were analyzed.
Results. In our study group, obesity and its abdominal form were more common among patients with hypertension. A decrease in the testosterone level (< 12.1 nmol/l) was significantly more common among patients with hypertension (64.91 versus 41.98%; p ≤ 0.001). Differences in the prevalence of hyperestrogenism (estradiol level above 41.2 pg/ml) did not reach statistically significant values (29.43 versus 22.22%; p = 0.064). When dividing the study sample by estradiol tertiles, the groups significantly differed from each other in the prevalence of hypertension (p = 0.028). According to the results of multivariate logistic analysis, sex hormones made a significant contribution to the model of the presence of hypertension. High levels of estradiol were associated with a higher probability of hypertension, while lower levels reduced the probability of hypertension. The relationship between testosterone and hypertension was inverse: the higher the level of this hormone, the lower the probability of hypertension in young and middle-aged men.
Conclusions. Our study shows the presence of an independent relationship between the level of testosterone and estradiol and the presence of hypertension in young and middle-aged men.
Keywords
Full Text
About the authors
Iana A. Orlova
Lomonosov Moscow State University
Email: YAOrlova@mc.msu.ru
ORCID iD: 0000-0002-8160-5612
SPIN-code: 3153-8373
MD, PhD, Professor
Russian Federation, MoscowEgor D. Sorokin
Lomonosov Moscow State University
Author for correspondence.
Email: srknegor@gmail.com
ORCID iD: 0009-0002-5730-4286
SPIN-code: 3601-1377
MD
Russian Federation, 27 bldg 10 Lomonosovsky Prospekt, 119991, MoscowZukhra Sh. Pavlova
Lomonosov Moscow State University
Email: zukhra73@gmail.com
ORCID iD: 0000-0001-7954-0437
SPIN-code: 9329-7628
MD, PhD
Russian Federation, MoscowAlina G. Plisyuk
Lomonosov Moscow State University
Email: apl.cardio@yandex.ru
ORCID iD: 0000-0003-2015-4712
SPIN-code: 3541-2077
MD, PhD, Assistant Professor
Russian Federation, MoscowKirill P. Raevskii
Lomonosov Moscow State University
Email: raevskiikp@my.msu.ru
ORCID iD: 0000-0002-9939-3443
SPIN-code: 9133-3802
Russian Federation, Moscow
Armais A. Kamalov
Lomonosov Moscow State University
Email: armais.kamalov@rambler.ru
ORCID iD: 0000-0003-4251-7545
SPIN-code: 6609-5468
MD, PhD, Professor, Academician of the RAS
Russian Federation, MoscowReferences
- Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. The Lancet. 2020;395(10226):795-808. doi: 10.1016/S0140-6736(19)32008-2
- Кобалава Ж.Д., Конради А.О., Недогода С.В., и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2024 // Российский кардиологический журнал. – 2024. – Vol. 29, N 9. – P.6117. [Kobalava ZD, Konradi AO, Nedogoda S V., et al. 2024 Clinical practice guidelines for Hypertension in adults. Russian Journal of Cardiology. 2024;29(9):6117. doi: 10.15829/1560-4071-2024-6117]
- Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control. Circulation. 2016;134(6):441-450. doi: 10.1161/CIRCULATIONAHA.115.018912/SUPPL_FILE/MILLS_441.PDF
- Connelly PJ, Casey H, Montezano AC, Touyz RM, Delles C. Sex steroids receptors, hypertension, and vascular ageing. J Hum Hypertens. 2021;36(2):120. doi: 10.1038/S41371-021-00576-7
- Бойцов С. А., Баланова Ю. А., Шальнова С. А., и др. АРТЕРИАЛЬНАЯ ГИПЕРТОНИЯ СРЕДИ ЛИЦ 25-64 ЛЕТ: РАСПРОСТРАНЕННОСТЬ, ОСВЕДОМЛЕННОСТЬ, ЛЕЧЕНИЕ И КОНТРОЛЬ. ПО МАТЕРИАЛАМ ИССЛЕДОВАНИЯ ЭССЕ // Кардиоваскулярная терапия и профилактика. – 2014. – Vol. 13, N 4. – P.4–14. [Boytsov S.A., Balanova Yu.A., Shalnova S.A., et al. ARTERIAL HYPERTENSION AMONG INDIVIDUALS OF 25–64 YEARS OLD: PREVALENCE, AWARENESS, TREATMENT AND CONTROL. BY THE DATA FROM ECCD. Cardiovascular Therapy and Prevention. 2014;13(4):4-14. doi: 10.15829/1728-8800-2014-4-4-14]
- Ji H, Kim A, Ebinger JE, et al. Sex Differences in Blood Pressure Trajectories Over the Life Course. JAMA Cardiol. 2020;5(3):255-262. doi: 10.1001/JAMACARDIO.2019.5306
- Feldman HA, Longcope C, Derby CA, et al. Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87(2):589-598. doi: 10.1210/JCEM.87.2.8201
- Marriott RJ, Harse J, Murray K, Yeap BB. Systematic review and meta-analyses on associations of endogenous testosterone concentration with health outcomes in community-dwelling men. BMJ Open. 2021;11(11). doi: 10.1136/BMJOPEN-2020-048013
- Mazer NA. A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: With illustrative examples from male and female populations. Steroids. 2009;74(6):512-519. doi: 10.1016/J.STEROIDS.2009.01.008
- Swislocki ALM, Eisenberg ML. A Review on Testosterone: Estradiol Ratio—Does It Matter, How Do You Measure It, and Can You Optimize It? World J Mens Health. 2024;42. doi: 10.5534/WJMH.240029
- Орлова Я.А., Сорокин Е.Д., Павлова З.Ш., и др. Оценка связи риска развития сердечно-сосудистых заболеваний с уровнем эстрадиола у мужчин молодого и среднего возраста // Кардиология. – 2023. – Vol. 63, N 9. – P.14–19. [Orlova IA, Sorokin ED, Pavlova ZS, Plisyuk AG, Kamalov AA. Linking Cardiovascular Risk With Estradiol Level in Men. Kardiologiia. 2023;63(9):14-19. doi: 10.18087/CARDIO.2023.9.N2450]
- Бойцов С. А., Погосова Н. В., Аншелес А. А., и др. Кардиоваскулярная профилактика 2022. Российские национальные рекомендации // Российский кардиологический журнал. – 2023. – Vol. 28, N 5. – P.5452. [Boytsov S.A., Pogosova N.V., Ansheles A.A., et al. Cardiovascular prevention 2022. Russian national guidelines. Russian Journal of Cardiology. 2023;28(5):5452. doi: 10.15829/1560-4071-2023-5452]
- Эндокринология. Национальное Руководство. / под редакцией Дедова И. И., Мельниченко Г. А. – 2 издание – М.: ГЭОТАР-Медиа; 2024. [Dedov I.I., Mel'nichenko G. A., et al. Endokrinologiya. Nacionalnoe Rukovodstvo. 2nd ed. GEOTAR, media publishing group; 2024]
- Home - Mayo Clinic Laboratories. Accessed January 1, 2025. https://www.mayocliniclabs.com/
- Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2011;96(10):3007. doi: 10.1210/JC.2011-1137
- Yeap BB, Marriott RJ, Antonio L, et al. Serum Testosterone is Inversely and Sex Hormone-binding Globulin is Directly Associated with All-cause Mortality in Men. J Clin Endocrinol Metab. 2021;106(2):E625-E637. doi: 10.1210/CLINEM/DGAA743
- Menke A, Guallar E, Rohrmann S, et al. Sex steroid hormone concentrations and risk of death in US men. Am J Epidemiol. 2010;171(5):583-592. doi: 10.1093/AJE/KWP415
- Traish AM, Zitzmann M. The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease. Rev Endocr Metab Disord. 2015;16(3):249-268. doi: 10.1007/S11154-015-9323-2
- Qu M, Feng C, Wang X, et al. Association of Serum Testosterone and Luteinizing Hormone With Blood Pressure and Risk of Cardiovascular Disease in Middle-Aged and Elderly Men. J Am Heart Assoc. 2021;10(7). doi: 10.1161/JAHA.120.019559
- Chen BT, Tsai PJ, Jiann BP. Association of total testosterone levels with cardiometabolic diseases in men with erectile dysfunction. Sex Med. 2025;12(6). doi: 10.1093/SEXMED/QFAE089
- Visniauskas B, Kilanowski-Doroh I, Ogola BO, et al. Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases. J Hum Hypertens. 2022;37(8):609. doi: 10.1038/S41371-022-00771-0
- Орлова Я.А., Сорокин Е.Д., Павлова З.Ш., и др. Связь уровня эстрадиола с сердечно-сосудистыми осложнениями у мужчин по данным систематического обзора // Вестник Российской академии медицинских наук. – 2024. – Vol. 79, N 3. – P.205–215. [Orlova IA, Sorokin ED, Pavlova ZS, Plisyuk AG, Kamalov AA. Estradiol Level as a Risk Factor for Cardiovascular Endpoints in Men: A Systematic Review. Vestn Ross Akad Med Nauk. 2024;79(3):205-215. doi: 10.15690/vramn17954]
- Khaw KT, Barrett-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship. J Hypertens. 1988;6(4):328???332. doi: 10.1097/00004872-198804000-00010
- Swica Y, Warren MP, Manson JE, et al. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women’s Health Initiative hormone therapy trials. Menopause. 2018;25(7):753-761. doi: 10.1097/GME.0000000000001067
- The Coronary Drug Project: Findings Leading to Discontinuation of the 2.5-mg/day Estrogen Group. JAMA. 1973;226(6):652-657. doi: 10.1001/JAMA.1973.03230060030009
- Jaiswal V, Sawhney A, Nebuwa C, et al. Association between testosterone replacement therapy and cardiovascular outcomes: A meta-analysis of 30 randomized controlled trials. Prog Cardiovasc Dis. 2024;85:45-53. doi: 10.1016/J.PCAD.2024.04.001
- Boardman HMP, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database of Systematic Reviews. 2015;2015(3). doi: 10.1002/14651858.CD002229.PUB4/MEDIA/CDSR/CD002229/URN:X-WILEY:14651858:MEDIA:CD002229:CD002229-CMP-003-05
- Ding EL, Song Y, Manson JE, et al. Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and Men. New England Journal of Medicine. 2009;361(12):1152-1163. doi: 10.1056/NEJMOA0804381/SUPPL_FILE/NEJM_DING_1152SA1.PDF
- Li C, Ford ES, Li B, Giles WH, Liu S. Association of Testosterone and Sex Hormone–Binding Globulin With Metabolic Syndrome and Insulin Resistance in Men. Diabetes Care. 2010;33(7):1618-1624. doi: 10.2337/DC09-1788
- Li J, Zheng L, Chan KHK, et al. Sex Hormone-Binding Globulin and Risk of Coronary Heart Disease in Men and Women. Clin Chem. 2023;69(4):374-385. doi: 10.1093/CLINCHEM/HVAC209
Supplementary files
